---
truth_dimension: procedural
authority_level: authoritative
mutation_path: checklist_revision
---

# Current phase checklist

## Phase name
Phase 160 - Production-Path Alignment Checkpoint.

## Phase goal
- [x] Reconcile the Phase 151-159 local beta product-capability block.
- [x] Decide whether AJENTIC may proceed toward controlled internal trial packaging.
- [x] Remap Phases 161-170 without implementing Phase 161.

## Working-tree hygiene gate
- [x] Start from a clean working tree.
- [x] Keep edits limited to allowed Phase 160 surfaces.
- [x] Do not modify Rust source, TypeScript source, tests, schemas, scripts, CI workflows, README.md, AGENTS.md, governance docs, architecture docs, archived changelog files, package files, lockfiles, release infrastructure, deployment infrastructure, or installer/update/signing/publishing behavior.

## Allowed surfaces
- [x] `docs/roadmap/phase-map.md`
- [x] `docs/roadmap/phases.md`
- [x] `docs/roadmap/sequencing.md`
- [x] `docs/roadmap/phase-160-production-path-alignment.md`
- [x] `CHANGELOG.md`
- [x] `checklists/current-phase.md`

## Phase 151 carry-forward checklist
- [x] Local session package artifact reconciled.
- [x] Session package is not a release artifact.

## Phase 152 carry-forward checklist
- [x] Session history and restore UI reconciled.
- [x] Restore projection is not recovery promotion.

## Phase 153 carry-forward checklist
- [x] Real local provider adapter contract reconciled.
- [x] Adapter contract does not approve provider trust.

## Phase 154 carry-forward checklist
- [x] Controlled deterministic adapter dry-run harness reconciled.
- [x] Adapter dry run remains bounded and non-production.

## Phase 156 carry-forward checklist
- [x] One constrained local provider invocation path reconciled.
- [x] No provider execution expansion approved.

## Phase 157 carry-forward checklist
- [x] Provider output pipeline integration reconciled.
- [x] Provider output remains untrusted unless a later explicit bounded phase changes that.

## Phase 158 carry-forward checklist
- [x] Local candidate materialization reconciled.
- [x] Local candidate materialization is not production approval.

## Phase 159 carry-forward checklist
- [x] Complete local operator workflow projection and UI reconciled.
- [x] Local beta workflow completion is not production readiness.

## Local beta workflow status checklist
- [x] Provider setup included.
- [x] Constrained invocation included.
- [x] Provider output pipeline included.
- [x] Validation/review included.
- [x] Staged proposal included.
- [x] Staged validation included.
- [x] Candidate review included.
- [x] Operator decision included as local workflow decision only.
- [x] Local candidate materialization included.
- [x] Replay/status included.
- [x] Evidence export included and not release evidence.
- [x] Session package included and not a release artifact.
- [x] Restore/history included.

## Controlled internal trial packaging blocker checklist
- [x] Controlled internal trial package/checklist bundle remains to be produced in Phase 161.
- [x] Trial operator runbook and failure drilldown UI remains to be produced in Phase 162.
- [x] Trial-session evidence artifact remains to be produced in Phase 163.
- [x] Trial replay and restore verification remains to be produced in Phase 164.
- [x] Controlled internal trial execution harness remains to be produced in Phase 166.
- [x] Trial observability/error reporting remains to be produced in Phase 167.
- [x] Trial evidence review surface remains to be produced in Phase 168.
- [x] Local beta hardening remains to be produced in Phase 169 from confirmed trial evidence.

## Authority boundary preservation checklist
- [x] Local beta workflow completion is not production readiness.
- [x] Local candidate materialization is not production approval.
- [x] Provider output remains untrusted unless a later explicit bounded phase changes that.
- [x] Evidence export is not release evidence.
- [x] Session package is not a release artifact.
- [x] Restore projection is not recovery promotion.
- [x] Replay/status projection is not replay repair.
- [x] Operator decisions are local workflow decisions, not release/deployment/public-use approvals.
- [x] Passing validation is not readiness approval.
- [x] Absence of blockers is not approval.
- [x] Phase 160 is not public/general use approval.
- [x] Phase 160 is not release readiness approval.
- [x] Phase 160 is not deployment approval.

## Phase 161 gate decision checklist
- [x] Decision: `proceed_with_caveats_to_controlled_internal_trial_packaging`.
- [x] Phase 161 is expected to resume code production.
- [x] Phase 161 must produce a local-only controlled internal trial package/checklist bundle.
- [x] Phase 161 must not create public release, installer/update-channel, signing, publishing, deployment, provider trust, action execution, or readiness approval behavior.

## Phase 161-170 remap checklist
- [x] Phase 161 - Controlled Internal Trial Package.
- [x] Phase 162 - Trial Operator Runbook and Failure Drill UI.
- [x] Phase 163 - Trial Session Evidence Capture.
- [x] Phase 164 - Trial Replay and Restore Verification.
- [x] Phase 165 - Code-Production Alignment Checkpoint; alignment only.
- [x] Phase 166 - Controlled Internal Trial Execution Harness.
- [x] Phase 167 - Trial Observability and Error Reporting.
- [x] Phase 168 - Trial Evidence Review Surface.
- [x] Phase 169 - Local Beta Hardening Pass.
- [x] Phase 170 - Production-Path Alignment Checkpoint; alignment only.
- [x] Non-0/5 phases must produce product-facing code, executable artifacts, or operator-visible workflow improvements.
- [x] 0/5 phases remain alignment checkpoints only.

## No-implementation checklist
- [x] No Rust source changes.
- [x] No TypeScript source changes.
- [x] No test changes.
- [x] No schema changes.
- [x] No runtime behavior.
- [x] No provider execution expansion.
- [x] No persistence implementation.
- [x] No release artifact creation.
- [x] No deployment behavior.
- [x] No installer, update-channel, signing, publishing, public-use, or readiness approval behavior.

## Validation checklist
- [x] `CARGO_TARGET_DIR=/tmp/ajentic-phase-160-target ./scripts/check.sh`
- [x] `git diff --check`
- [x] `git status --short`
- [x] Remap scan.
- [x] Local beta evidence scan.
- [x] Authority boundary scan.
- [x] No-source-drift guard.
- [x] Readiness/release/provider scan.
- [x] Implementation-drift scan.

## Deferred items
- [x] Phase 161 implementation.
- [x] Runtime behavior.
- [x] Provider execution expansion.
- [x] Persistence implementation.
- [x] Release artifacts.
- [x] Deployment behavior.
- [x] Installer, update-channel, signing, publishing behavior.
- [x] Public/general use approval.
- [x] Production readiness approval.
- [x] Release readiness approval.
- [x] Provider-output trust.
- [x] Candidate approval.
- [x] Action authorization.

## Validation log
- `CARGO_TARGET_DIR=/tmp/ajentic-phase-160-target ./scripts/check.sh` passed.
- `git diff --check` passed.
- `git status --short` showed only allowed Phase 160 files changed before commit.
- Remap scan completed with Phase 160-170 roadmap, changelog, and checklist matches.
- Local beta evidence scan completed with local beta workflow and Phase 151-159 evidence matches.
- Authority boundary scan completed with required non-approval boundary matches.
- No-source-drift guard produced no output.
- Readiness/release/provider scan produced no prohibited approval claims.
- Implementation-drift scan completed with required Phase 160 no-implementation matches.

## Zero-drift checklist
- [x] Full validation passes after final edits.
- [x] No masked failures exist.
- [x] Generated artifacts are cleaned.
- [x] Staged files match allowed Phase 160 surfaces.
- [x] Phase 151-159 implementation block is reconciled accurately.
- [x] Current local beta workflow is described accurately.
- [x] Phase 161 gate decision is explicit.
- [x] Phase 161-170 remap is present.
- [x] Phase 161 produces controlled internal trial package.
- [x] Phase 162 improves operator runbook/failure drill UI.
- [x] Phase 163 captures trial session evidence.
- [x] Phase 164 verifies trial replay/restore.
- [x] Phase 165 remains alignment-only.
- [x] Phase 166 introduces controlled internal trial execution harness.
- [x] Phase 167 adds local trial observability/error reporting.
- [x] Phase 168 adds trial evidence review surface.
- [x] Phase 169 performs local beta hardening.
- [x] Phase 170 remains production-path alignment checkpoint.
- [x] Non-0/5 product-capability rule is preserved.
- [x] 0/5 alignment checkpoint rule is preserved.
- [x] Local beta workflow completion is not production readiness.
- [x] Local candidate materialization is not production approval.
- [x] Provider output remains untrusted.
- [x] Evidence export is not release evidence.
- [x] Session package is not a release artifact.
- [x] Restore projection is not recovery promotion.
- [x] Replay/status projection is not replay repair.
- [x] No Rust/TypeScript/test/schema/script drift is introduced.
- [x] No runtime behavior is introduced.
- [x] No readiness, release, deployment, signing, publishing, provider-output trust, candidate approval, public-use, or production approval is introduced.
- [x] CHANGELOG entry matches actual diff.
- [x] Phase 161 remains the next code-production phase.
